• Skip to primary navigation
  • Skip to main content
  • Skip to primary sidebar

information for practice

news, new scholarship & more from around the world


advanced search
  • gary.holden@nyu.edu
  • @ Info4Practice
  • Archive
  • About
  • Help
  • Browse Key Journals
  • RSS Feeds

Is Fibromyalgia An Endocrine/Endorphin Deficit Disorder? Is Low Dose Naltrexone a New Treatment Option? – Corrected Proof

Fibromyalgia is a chronic pain syndrome. Neuman and Buskila noted that fibromyalgia afflicts approximately 5% of women and 1.6% of men. The diagnosis of fibromyalgia is primarily based on chronic widespread pain that has (1) pain on both sides of the body, (2) is above and below the waist, (3) should involve the axial skeleton, and (4) must have been present for more than 3 months. Physical examination must include at least 11 of 18 tender points. In clinical practice, nearly half the population may have fewer tender points. A new proposed fibromyalgia syndrome also includes sleep deficits, daytime fatigue, and altered cognition/mood as a part of the syndrome. Comorbid psychiatric disorders are common in fibromyalgia. Arnold et al. reported that 75% of patients with fibromyalgia have a mood disorder, 60% have an anxiety disorder, and 26% have a substance use disorder.

Posted in: Journal Article Abstracts on 04/05/2012 | Link to this post on IFP |
Share

Primary Sidebar

Categories

Category RSS Feeds

  • Calls & Consultations
  • Clinical Trials
  • Funding
  • Grey Literature
  • Guidelines Plus
  • History
  • Infographics
  • Journal Article Abstracts
  • Meta-analyses - Systematic Reviews
  • Monographs & Edited Collections
  • News
  • Open Access Journal Articles
  • Podcasts
  • Video

© 1993-2025 Dr. Gary Holden. All rights reserved.

gary.holden@nyu.edu
@Info4Practice